Expert: Device tax could produce medical product supply snafus

Get ready for higher prices and supply problems for crucial medical products once the 2.3% medical device industry tax kicks in on Jan. 1, a healthcare expert predicts. Beyond pacemakers and stents, the tax will also likely cover things such as wheelchairs or surgical gloves, and the extra cost could cause problems for long-term care providers making purchases, John McLean of the life sciences practice at the executive search firm Witt/Kieffer told McKnight's Long-Term Care News & Assisted Living. He also argued, as others have, that the tax could harm newer companies developing novel devices, and hamper innovation as a result. Story

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.